Terms: = Uterine cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Diagnosis
158 results:
1. Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
[TBL] [Abstract] [Full Text] [Related]
2. mlh1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.
Helderman NC; Andini KD; van Leerdam ME; van Hest LP; Hoekman DR; Ahadova A; Bajwa-Ten Broeke SW; Bosse T; van der Logt EMJ; Imhann F; Kloor M; Langers AMJ; Smit VTHBM; Terlouw D; van Wezel T; Morreau H; Nielsen M
J Mol Diagn; 2024 Feb; 26(2):106-114. PubMed ID: 38061582
[TBL] [Abstract] [Full Text] [Related]
3. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
[TBL] [Abstract] [Full Text] [Related]
4. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
5. Comparison of Methods for Testing Mismatch Repair Status in Endometrial cancer.
Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
[TBL] [Abstract] [Full Text] [Related]
6. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
PeerJ; 2023; 11():e15920. PubMed ID: 37663290
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
8. [Endometrioid adenocarcinoma with proliferated stromal cells, hyalinization and cord-like formations: A case report].
Ning BH; Zhang QX; Yang H; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):366-369. PubMed ID: 37042152
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome.
Sleiman J; Farha N; Beard J; Bena J; Morrison S; Milicia S; Heald B; Kalady MF; Church J; Liska D; Mankaney G; Burke CA
Gastrointest Endosc; 2023 Sep; 98(3):412-419.e8. PubMed ID: 37031913
[TBL] [Abstract] [Full Text] [Related]
10. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
11. mlh1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional mlh1 epimutation.
Hitchins MP; Alvarez R; Zhou L; Aguirre F; Dámaso E; Pineda M; Capella G; Wong JJ; Yuan X; Ryan SR; Sathe DS; Baxter MD; Cannon T; Biswas R; DeMarco T; Grzelak D; Hampel H; Pearlman R
Gynecol Oncol; 2023 Apr; 171():129-140. PubMed ID: 36893489
[TBL] [Abstract] [Full Text] [Related]
12. The statuses of HER2 expression and mismatch repair in endometrial clear cell carcinoma.
Bayramoglu Z; Erozbek SY; Ozdemir IA; Ulker V; Muezzinoglu B
Pathol Res Pract; 2023 Jan; 241():154258. PubMed ID: 36516643
[TBL] [Abstract] [Full Text] [Related]
13. [A family with clustered Lynch syndrome: a case report].
Zhu X; Cai L; Xiao J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1263-1266. PubMed ID: 36073228
[TBL] [Abstract] [Full Text] [Related]
14. Critical aspects of microsatellite instability testing in endometrial cancer: a comparison study.
Libera L; Sahnane N; Pepe F; Pisapia P; De Luca C; Russo G; Parente P; Covelli C; Chiaravalli AM; Sessa F; Malapelle U; Furlan D
Hum Pathol; 2022 Oct; 128():134-140. PubMed ID: 35872156
[TBL] [Abstract] [Full Text] [Related]
15. Microsatellite Instability-High Endometrial cancers with mlh1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Manning-Geist BL; Liu YL; Devereaux KA; Paula ADC; Zhou QC; Ma W; Selenica P; Ceyhan-Birsoy O; Moukarzel LA; Hoang T; Gordhandas S; Rubinstein MM; Friedman CF; Aghajanian C; Abu-Rustum NR; Stadler ZK; Reis-Filho JS; Iasonos A; Zamarin D; Ellenson LH; Lakhman Y; Mandelker DL; Weigelt B
Clin Cancer Res; 2022 Oct; 28(19):4302-4311. PubMed ID: 35849120
[TBL] [Abstract] [Full Text] [Related]
16. Impact of the new molecular classification of endometrial cancer: A French cohort study.
Benichou J; Schwall C; Sastre-Garau X; Méreaux J; Miailhe G; Bendifallah S; Haddad B; Touboul C; Mitri-Frangieh R; Dabi Y
Gynecol Oncol; 2022 Sep; 166(3):515-521. PubMed ID: 35843738
[TBL] [Abstract] [Full Text] [Related]
17. Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical cancer.
Dudea-Simon M; Mihu D; Pop LA; Ciortea R; Malutan AM; Diculescu D; Ciocan CA; Cojocneanu RM; Simon V; Bucuri C; Mocan-Hognogi R; Braicu C; Berindan-Neagoe I
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682732
[No Abstract] [Full Text] [Related]
18. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
[TBL] [Abstract] [Full Text] [Related]
19. Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the diagnosis and Management of Lynch Syndrome.
Buglyó G; Styk J; Pös O; Csók Á; Repiska V; Soltész B; Szemes T; Nagy B
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457101
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small cancer Panel.
Kobayashi Y; Kitazono I; Akahane T; Yanazume S; Kamio M; Togami S; Nohara S; Sakamoto I; Yokoyama S; Tabata K; Kobayashi H; Tanimoto A
Pathol Oncol Res; 2021; 27():1610013. PubMed ID: 35002543
[TBL] [Abstract] [Full Text] [Related]
[Next]
